ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 9.27
+0.06 (0.65%)
Sep 1, 2026, 4:00 PM EDT
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 4.62 billion as of September 1, 2026. Its market cap has decreased by -27.18% in one year.
Market Cap
4.62B
Enterprise Value
4.59B
Revenue
1.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
9.27
ChartMarket Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 4.62B, an increase of 117.69%. That is a compound annual growth rate of 5.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 4.62B | -3.03% |
| Dec 31, 2025 | 4.76B | 49.45% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Biotest Biotech | 5.41B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.20B |
| Shenzhen Weiguang Biological Products | 5.15B |
| Novoprotein Scientific | 5.11B |
| Boji Medical Technology | 5.07B |
| R&G PharmaStudies | 5.00B |
| Beijing Konruns Pharmaceutical | 4.84B |
| Wuhan Hvsen Biotechnology | 4.66B |